Orion Biotechnology Canada Ltd

Orion is a clinical stage company leveraging a proprietary technology platform to develop next gen therapeutics for targeting G Protein-Coupled Receptors

[Orion Biotechnology Canada Ltd @orion_biotech]

As the year comes to a close, we would like to thank you for your support and may 2026 bring even greater achievements and new opportunities.

[Orion Biotechnology Canada Ltd @orion_biotech]

Our COO, Anatole Klepatsky, will be attending Bio Europe Spring. To learn more about Orion's pipeline of next-generation #obesity therapeutics, you can book a meeting with our team through the event's partnering platform.

#BioEuropeSpring #GPCR

[Orion Biotechnology Canada Ltd @orion_biotech]

Our COO, Anatole Klepatsky, will present Orion’s pipeline of next-gen obesity therapeutics at Sachs Associates 1st Annual Biopharma Obesity Innovation Forum on January 11th. Mr. Klepatsky will also be available for meetings during J.P. Morgan  healthcare conf.
#JPM25 #JPM2025

[Orion Biotechnology Canada Ltd @orion_biotech]

As we turn the page to a new year, we’re grateful for the support of our investors and partners. Together we can look forward to a productive 2025!

[Orion Biotechnology Canada Ltd @orion_biotech]

From all of us at Orion Biotechnology we want to take this moment to wish you and yours, best wishes for a happy holiday season and a safe and prosperous new year.

[Orion Biotechnology Canada Ltd @orion_biotech]

We’re pleased to announce that our VP Drug Discovery, Dr. Oliver Hartley, will be presenting at the GPCRs-Targeted Drug Discovery Summit Europe. Join Dr. Hartley to learn about Orion’s pipeline of next-gen therapeutics for obesity and metabolic disorders.
#GPCR #drugdiscovery

[Orion Biotechnology Canada Ltd @orion_biotech]

We're excited to share that we've launched our new website. You can follow the progression of our next-gen obesity programs, learn more about our innovative technology platform, and meet the Orion team.

https://t.co/S4NI7M11NB

[Orion Biotechnology Canada Ltd @orion_biotech]

Join Orion's COO, Anatole Klepatsky, at Bio-Europe from November 4-6 to learn more about Orion's pipeline of next-generation obesity therapies.
#BioEurope

[Orion Biotechnology Canada Ltd @orion_biotech]

We're pleased to share that our VP Drug Discovery, Dr. Oliver Hartley, will be presenting Orion’s pipeline of next-generation metabolic therapeutics at Discovery on Target.

#BostonDOT24  #GPCR #drugdiscovery

[Orion Biotechnology Canada Ltd @orion_biotech]

Simona Angerani will be presenting at the International Oligonucleotides and Peptides Conference in Milan. Ms. Angerani's presentation will demonstrate how Orion's PROcisionXTM platform unlocks small protein GPCRs. 
#grc #gpcr #drugdiscovery

[Orion Biotechnology Canada Ltd @orion_biotech]

Join Dr. Ian McGowan (CMO) and Jarret Engstrom (Director of Operations) at Bio International, from June 5-6, to learn about Orion’s progress in unlocking the therapeutic potential of small protein GPCRs.

#bio2023 #GPCR #drugdiscovery

[Orion Biotechnology Canada Ltd @orion_biotech]

It is with great sadness that we share news of the passing of a co-founder and a past chairman of our Orion Biotechnology’s Board of Directors, Mr. Rudolf (Ruud) Bom.

A brilliant business leader and trusted friend, Ruud will be greatly missed by all who knew him.

[Orion Biotechnology Canada Ltd @orion_biotech]

Register today to attend Dr. Oliver Hartley's presentation on small protein GPCRs at the Dr. GPCR Symposium.
https://t.co/hcTqN0s8Ha

[Orion Biotechnology Canada Ltd @orion_biotech]

Join Anatole Klepatsky (COO) and Dr. Ian McGowan (CMO) at Bio Equity Europe to learn about our progress in unlocking the therapeutic potential of small protein GPCRs.

#bioequity #drugdiscovery #gpcr

[Orion Biotechnology Canada Ltd @orion_biotech]

Orion’s COO, Anatole Klepatsky, will be participating in a panel discussion at the LSX World Congress. To connect with Mr. Klepatsky and Dr. Ian McGowan (CMO) in London, feel free to reach out through the event’s partnering platform.
#LSXWorld #biotech #gpcr

[Orion Biotechnology Canada Ltd @orion_biotech]

Join Anatole Klepatsky and Dr. Ian McGowan at Swiss Biotech Day to learn about our progress in unlocking the therapeutic potential of small protein GPCRs.
#swissbiotechday #GPCR #biotech

[Orion Biotechnology Canada Ltd @orion_biotech]

Join Anatole Klepatsky (COO) and Dr. Ian McGowan (CMO) at Bio-Europe Spring to learn about our progress in unlocking the therapeutic potential of small protein GPCRs.
#BIOEuropeSpring #drugdiscovery #GPCR

[Orion Biotechnology Canada Ltd @orion_biotech]

Check out our whitepaper highlighting the importance of GPCRs and current challenges in unlocking these important targets. It presents a new approach to rapidly target previously undruggable GPCRs leveraging the company’s PROcisionXᵀᴹ platform.
https://t.co/DlIlf73Hdd

[Orion Biotechnology Canada Ltd @orion_biotech]

Check out our latest white paper on targeting #Undruggable #GPCRs at the Fierce Biotech website https://t.co/BKNgpccgzB.

[Orion Biotechnology Canada Ltd @orion_biotech]

Join Dr. Oliver Hartley (VP Drug Discovery), on February 23rd to learn about our progress in unlocking the therapeutic potential of previously undruggable small protein #GPCRs. Dr. Hartley will be presenting at the 2nd GPCR-Targeted Drug Discovery Summit in Boston.
#drugdisovery